Pharmacist Involvement in Chemotherapy Induced Nausea and Vomiting Management: A Meta‐Analysis
Journal of Clinical Pharmacy and Therapeutics · 2026-01 · 2026 (1)
DOI: 10.1155/jcpt/8267674 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 31.03.2026. Verfasst von Xinmiao Lin und 6 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Fujian Provincial Health Technology Project.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
Most antineoplastic drugs are highly toxic and can cause drug‐related gastrointestinal reactions. This review aimed to critically appraise the impact of clinical pharmacists in reducing the intensity of nausea and vomiting following chemotherapy in cancer patients.
Methods
A search was conducted to retrieve studies from eight databases that assessed the extent of pharmacist intervention in relieving nausea and vomiting after chemotherapy in cancer patients from construction to February 2024.
Results
A total of 3077 records were retrieved, of which 20 met the inclusion criteria. The results demonstrated that the involvement of clinical pharmacists in the management of CINV in oncology patients was effective in increasing the rate of complete control of acute ( p < 0.001, RR = 1.21 [1.11–1.32]) and delayed ( p < 0.001, RR = 1.28 [1.02–1.59]) vomiting in chemotherapy patients. The incidence of nausea ( p < 0.001, RR = 0.77 [0.69–0.85]) and delayed nausea ( p < 0.001, RR = 0.67 [0.53–0.85]) in chemotherapy patients was also effectively mitigated. There was a significant improvement in patient adherence to oncology treatment ( p < 0.001, OR = 6.51 [3.18–13.35]).
Conclusion
Clinical pharmacists’ involvement in the management of CINV in patients undergoing cancer chemotherapy resulted in a reduction in the incidence of nausea and vomiting and improved patient adherence to treatment. The involvement of clinical pharmacists in the management of chemotherapy‐induced nausea and vomiting, either directly or as a key member of the multidisciplinary oncology team, is of significant importance.
Förderung
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Technology Project
Zitieren
APA
Lin, X., Zhang, L., Peng, P., Xie, M., Wei, X., Sun, H., & Cai, J. (2026). Pharmacist Involvement in Chemotherapy Induced Nausea and Vomiting Management: A Meta‐Analysis. Journal of Clinical Pharmacy and Therapeutics, 2026(1). https://doi.org/10.1155/jcpt/8267674
Vancouver
Lin X, Zhang L, Peng P, Xie M, Wei X, Sun H, et al. Pharmacist Involvement in Chemotherapy Induced Nausea and Vomiting Management: A Meta‐Analysis. Journal of Clinical Pharmacy and Therapeutics. 2026;2026(1). doi:10.1155/jcpt/8267674
BibTeX
@article{Lin2026,
author = {Lin, Xinmiao and Zhang, Lirong and Peng, Pingping and Xie, Mumu and Wei, XiaoXia and Sun, Hong and Cai, Jiaqin},
title = {Pharmacist Involvement in Chemotherapy Induced Nausea and Vomiting Management: A Meta‐Analysis},
journal = {Journal of Clinical Pharmacy and Therapeutics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jcpt/8267674}
}
EUVIMED